Suppr超能文献

锂掺杂介孔二氧化硅在预防不同癌细胞坏死及增加凋亡方面的应用。

Utilization of lithium incorporated mesoporous silica for preventing necrosis and increase apoptosis in different cancer cells.

作者信息

Saleh Kamel A, Aldulmani Sharah A A, Awwad Nasser S, Ibrahium Hala A, Asiri Tahani H, Hamdy Mohamed S

机构信息

2Department of Biology, Faculty of Science, King Khalid University, P.O. Box 9004, Abha, Saudi Arabia.

1Department of Chemistry, Faculty of Science, King Khalid University, P.O. Box 9004, Abha, Saudi Arabia.

出版信息

BMC Chem. 2019 Jan 30;13(1):8. doi: 10.1186/s13065-019-0535-5. eCollection 2019 Dec.

Abstract

There are many molecules used as a drug carrier. TUD-1 is a newly synthesized mesoporous silica (SM) molecule possess two important features; consists of mesoporous so it is very suitable to be drug carrier in addition to that it has the ability to induce apoptosis in cancer cells. However, the effect of TUD-1 appears to act as cell death inducer, regardless of whether it is necrosis or apoptosis. Unfortunately, recent studies indicate that a proportion of cells undergo necrosis rather than apoptosis, which limits the use of TUD-1 as a secure treatment. On the other hand, lithium considered as necrosis inhibitor element. Hence, the current study based on the idea of producing a new Li-TUD-1 by incorporated mesoporous silica (TUD-1 type) with lithium in order to produce a new compound that has the ability to activate apoptosis by mesoporous silica (TUD-1 type) and at the same time can inhibit the activity of necrosis by lithium. Herein, lithium incorporated in TUD-1 mesoporous silica by using sol-gel technique in one-step synthesis procedure. Moreover, lithium incorporated in TUD-1 with different loading in order to form different active sites such as isolated lithium ions, nanoparticles of LiO, and bulky crystals of LiO. The ability of the new compounds to induce apoptosis and prevent necrosis was evaluated on three different types of cancer cell lines, which are; liver HepG-2, breast MCF-7, and colon HCT116. The obtained results show that Li-TUD-1 has the ability to control necrosis and thus reduce the side effects of treatments containing silica in the case of lithium added to them, especially in chronic cases. This opinion has demonstrated by the significant increase in the IC value and cell viability compared to control groups. Consequently, the idea is new, so it needs more develop and test with materials that have a more apoptotic impact than silica to induce apoptosis without induction of necrosis.

摘要

有许多分子可作为药物载体。TUD - 1是一种新合成的介孔二氧化硅(SM)分子,具有两个重要特性:它由介孔组成,因此非常适合作为药物载体,此外它还具有诱导癌细胞凋亡的能力。然而,TUD - 1的作用似乎是作为细胞死亡诱导剂,无论其是坏死还是凋亡。不幸的是,最近的研究表明,一部分细胞会发生坏死而非凋亡,这限制了TUD - 1作为一种安全治疗方法的应用。另一方面,锂被认为是坏死抑制元素。因此,当前的研究基于将介孔二氧化硅(TUD - 1型)与锂结合以生产一种新的Li - TUD - 1的想法,目的是制备一种新的化合物,该化合物既能通过介孔二氧化硅(TUD - 1型)激活凋亡,同时又能通过锂抑制坏死活性。在此,通过溶胶 - 凝胶技术在一步合成过程中将锂掺入TUD - 1介孔二氧化硅中。此外,以不同的负载量将锂掺入TUD - 1中,以形成不同的活性位点,如孤立的锂离子、LiO纳米颗粒和LiO大晶体。在三种不同类型的癌细胞系上评估了新化合物诱导凋亡和预防坏死的能力,这三种癌细胞系分别是:肝癌HepG - 2、乳腺癌MCF - 7和结肠癌HCT116。所得结果表明,Li - TUD - 1具有控制坏死的能力,从而在添加锂的情况下减少含二氧化硅治疗的副作用,尤其是在慢性病例中。与对照组相比,IC值和细胞活力的显著增加证明了这一观点。因此,这个想法是新颖的,所以需要用比二氧化硅具有更强凋亡作用的材料进行更多的开发和测试,以在不诱导坏死的情况下诱导凋亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5526/6661819/96fb5740eb50/13065_2019_535_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验